Covidien Pharmaceuticals Outsourcing (Formerly Mallinckrodt Pharmaceuticals Outsourcing)
|
|
Company Description:
|
Mallinckrodt and its former parent company, Tyco/Healthcare, are now Covidien, a $10 billion global leader in pharmaceuticals, medical devices/supplies, diagnostic imaging agents, and other healthcare products and services. As part of Covidien, we are better positioned than ever to give your contract manufacturing product the high level of accountability and attention it deserves. |
Additional Information:
Covidien Pharmaceuticals Outsourcing (Formerly Mallinckrodt Pharmaceuticals Outsourcing) deals in the following categories:
| Analytical Methods Development |
Analytical Validation Studies |
| Blending |
Contract Manufacturing |
| Dissolution Testing |
Encapsulation |
| Filling, Capsule |
Fluid Bed Processing |
| HPLC |
IND/NDA Submissions |
| Manufacturing, Capsules |
Manufacturing, Clinical Trials Supply |
| Manufacturing, Controlled Substances |
Manufacturing, Ethical |
| Manufacturing, Generics |
Manufacturing, Liquids |
| Manufacturing, Solid Dosage |
Manufacturing, Solutions & Suspensions |
| Manufacturing, Sustained Release |
Microencapsulation |
| Packaging, Blister |
Packaging, Capsules |
| Packaging, Form/Fill/Seal |
Packaging, Liquids |
| Packaging, Solid Dosage |
Packaging, Unit Dosage |
| QA/QC |
Scale-Up |
| Tablet Coating |
Validation, Manufacturing |
|
